Related Experiment Video

Updated: Feb 3, 2026

Studying Triple Negative Breast Cancer Using Orthotopic Breast Cancer Model
09:29

Studying Triple Negative Breast Cancer Using Orthotopic Breast Cancer Model

Published on: March 20, 2020

18.9K

Targeted and immuno-biology driven treatment strategies for triple-negative breast cancer: current knowledge and

Carlo Fremd1, Dirk Jaeger1, Andreas Schneeweiss1

  • 1a National Center for Tumor Diseases, Department of Medical Oncology , University of Heidelberg , Heidelberg , Germany.

Expert Review of Anticancer Therapy
|October 24, 2018
PubMed

Insights

Triple-negative breast cancer (TNBC) treatments face challenges due to resistance and heterogeneity. Advances in immunotherapy and targeted therapies like PARP inhibitors show promise for improving outcomes in TNBC patients.

Area of Science:

  • Oncology
  • Immunology
  • Genetics

Background:

  • Triple-negative breast cancer (TNBC) accounts for 15% of breast cancer cases and 25% of deaths.
  • TNBC is characterized by distant spread, visceral metastasis, primary resistance, and tumor heterogeneity.
  • Current treatments for TNBC have limited efficacy, necessitating novel therapeutic strategies.

Purpose of the Study:

  • To review the current status of immunological and targeted treatments for TNBC.
  • To provide a hypothesis-driven perspective on recent molecular, genetic, and immunologic insights.
  • To summarize preclinical studies and ongoing clinical trials for TNBC therapies.

Main Methods:

  • Review of recent preclinical studies and ongoing clinical trials.
  • Summary of immune-checkpoint blockade strategies.
  • Analysis of resistance mechanisms and targeted therapies, including PARP inhibitors.

Main Results:

  • Immune-checkpoint blockade has shown sustained responses in TNBC.
  • PARP inhibitors demonstrate significant efficacy in TNBC with germline BRCA mutations.
  • Combinatorial strategies are being explored to enhance treatment effectiveness.

Conclusions:

  • Integration of multidimensional data is crucial for clinical success of TNBC therapies.
  • Targeted and immune therapies hold promise but require further development and validation.
  • Accelerated treatment progress in TNBC is anticipated with advanced data integration.
Keywords:
BRCAPARPPD-1PD-L1Triple-negative breast cancerimmune checkpoint blockadepembrolizumabresistancetargeted therapy

More Related Videos

Studying Pancreatic Cancer Stem Cell Characteristics for Developing New Treatment Strategies07:29

Studying Pancreatic Cancer Stem Cell Characteristics for Developing New Treatment Strategies

Published on: June 20, 2015

20.2K
Orthotopic Transplantation of Breast Tumors as Preclinical Models for Breast Cancer07:45

Orthotopic Transplantation of Breast Tumors as Preclinical Models for Breast Cancer

Published on: May 18, 2020

7.0K

Related Concept Videos

Treatment Strategies for Psychological Disorders01:24

Treatment Strategies for Psychological Disorders

Treatment approaches for psychological disorders fall into three main categories: psychological, biological, and sociocultural. Each approach targets different aspects of mental health, requiring varying levels of education and training.
Psychological therapies focus on modifying emotions, thoughts, and behaviors through talking, interpreting, listening, rewarding, challenging, and modeling. Clinical psychologists, counselors, and social workers commonly practice psychotherapy. Clinical...
776
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.8K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.9K
Psychodynamic Perspectives on Personality01:27

Psychodynamic Perspectives on Personality

The psychodynamic perspective in psychology asserts that most personality functions operate unconsciously, outside of awareness. This means that the motives and emotions driving behavior often remain hidden, automatically buried in the unconscious mind as a defense mechanism to shield us from psychological distress. According to this theory, the unconscious mind contains thoughts, memories, and emotions that are too disturbing to face directly.
Psychodynamic theorists argue that unconscious...
1.6K
Persuasion Strategies01:52

Persuasion Strategies

Researchers have tested many persuasion strategies, including the foot-in-the door and the door-in-the-face techniques, in a variety of contexts. Ultimately, the principles are effective in selling products and changing people’s attitude, ideas, and behaviors (Cialdini & Goldstein, 2004).
43.5K
Scalar and Vector Triple Products01:06

Scalar and Vector Triple Products

Two vectors can be multiplied using a scalar product or a vector product. The resultant of a scalar product is scalar, while with vector products, the resultant is a vector. These rules of the scalar or vector product between two vectors can be applied to multiple vectors to obtain meaningful combinations. The scalar triple product is the dot product of a vector with the cross product of two vectors.
The scalar triple product is the dot product of a vector with the cross product of two vectors....
4.5K